Literature DB >> 23446080

Topical treatment of neuropathic pain using compounded medications.

Eyal Zur1.   

Abstract

BACKGROUND: The current medical treatment of neuropathic pain (NP) is inadequate with more than two thirds of patients having no suitable solution for their morbid disease and deteriorating quality of life. Currently, medications for the treatment of NP are mostly systemic (affecting the central nervous system) and are dose limited because of serious and debilitating adverse effects. Scientific evidence suggests that localized cutaneous NP can be treated effectively and safely by topical medications; however, only a few topical medications are indicated for NP. This lack of topica medications stems from the limited resources that have been dedicated to exploring the role of the peripheral nervous system in NP or to the development of peripherally active topical analgesics.
OBJECTIVES: To explore the evidence supporting the role of topical medications and the role of an expert compounding pharmacist in compounding effective and safe topical preparations to treat NP.
METHODS: A narrative review.
RESULTS: Well-designed randomized control trials and increasing number of case reports have shown positive results regarding a few topical compounded medications for the treatment of various pathologies of NP. This review summarizes the relevant scientific data supporting the use of topical medication in treating certain types of NP. DISCUSSION: This article discusses the role of topical medications in treating localized cutaneous NP and the role of the compounding pharmacists in applying this therapeutic approach (eg, the scientific considerations that the pharmacist should take into account).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23446080     DOI: 10.1097/AJP.0b013e318285d1ba

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  8 in total

1.  Trachyspermum ammi 10 % topical cream versus placebo on neuropathic pain, a randomized, double-blind, placebo-controlled trial.

Authors:  Peyman Petramfar; Mahmoodreza Moein; Soliman Mohammadi Samani; Sayed Hamidreza Tabatabaei; Mohammad M Zarshenas
Journal:  Neurol Sci       Date:  2016-05-11       Impact factor: 3.307

Review 2.  Spinal α2 -adrenoceptors and neuropathic pain modulation; therapeutic target.

Authors:  Zahra Bahari; Gholam Hossein Meftahi
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

Review 3.  Topical analgesics for neuropathic pain in the elderly: current and future prospects.

Authors:  Jana Sawynok
Journal:  Drugs Aging       Date:  2014-12       Impact factor: 3.923

Review 4.  Topical Treatments for Localized Neuropathic Pain.

Authors:  Roberto Casale; Z Symeonidou; M Bartolo
Journal:  Curr Pain Headache Rep       Date:  2017-03

5.  Efficacy of a topical gabapentin gel in a cisplatin paradigm of chemotherapy-induced peripheral neuropathy.

Authors:  Muhammad Shahid; Fazal Subhan; Nisar Ahmad; Robert D E Sewell
Journal:  BMC Pharmacol Toxicol       Date:  2019-08-28       Impact factor: 2.483

Review 6.  Challenges of neuropathic pain: focus on diabetic neuropathy.

Authors:  Daniela C Rosenberger; Vivian Blechschmidt; Hans Timmerman; André Wolff; Rolf-Detlef Treede
Journal:  J Neural Transm (Vienna)       Date:  2020-02-08       Impact factor: 3.575

7.  Co-Combination of Pregabalin and Withaniacoagulans-Extract-Loaded Topical Gel Alleviates Allodynia and Hyperalgesia in the Chronic Sciatic Nerve Constriction Injury for Neuropathic Pain in Animal Model.

Authors:  Anam Asghar; Muhammad Naeem Aamir; Fatima Akbar Sheikh; Naveed Ahmad; Mervat A Elsherif; Syed Nasir Abbas Bukhari
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

8.  Novel Treatment of Radicular Pain With a Multi-Mechanistic Combination Topical Agent: A Case Series and Literature Review.

Authors:  Pegah Safaeian; Ryan Mattie; Matthew Hahn; Christopher T Plastaras; Zachary L McCormick
Journal:  Anesth Pain Med       Date:  2016-03-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.